{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T08:36:00Z","timestamp":1792917360894,"version":"4.5.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Perioperative management of antithrombotic therapy is a situation that occurs frequently and requires consideration of the patient, the procedure, and an expanding array of anticoagulant and antiplatelet agents. Preoperative assessment must address each patient's risk for thromboembolic events balanced against the risk for perioperative bleeding. Procedures can be separated into those with a low bleeding risk, which generally do not require complete reversal of the antithrombotic therapy, and those associated with an intermediate or high bleeding risk. For patients who are receiving warfarin who need interruption of the anticoagulant, consideration must be given to whether simply withholding the anticoagulant is the optimal approach or whether a perioperative \u201cbridge\u201d with an alternative agent, typically a low-molecular-weight heparin, should be used. The new oral anticoagulants dabigatran and rivaroxaban have shorter effective half-lives, but they introduce other concerns for perioperative management, including prolonged drug effect in patients with renal insufficiency, limited experience with clinical laboratory testing to confirm lack of residual anticoagulant effect, and lack of a reversal agent. Antiplatelet agents must also be considered in the perioperative setting, with particular consideration given to the potential risk for thrombotic complications in patients with coronary artery stents who have antiplatelet therapy withheld.<\/jats:p>","DOI":"10.1182\/blood-2012-05-423228","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T05:32:22Z","timestamp":1343885542000},"page":"4699-4705","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":66,"title":["Perioperative management of patients on chronic antithrombotic therapy"],"prefix":"10.1182","volume":"120","author":[{"given":"Thomas L.","family":"Ortel","sequence":"first","affiliation":[{"name":"Hemostasis and Thrombosis Center, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020071613173357100_B1","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [erratum appears in Chest. 2012;141(4):1129].","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"2020071613173357100_B2","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence Based Clinical Practice Guidelines (8th Ed).","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"issue":"1","key":"2020071613173357100_B3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood-2009-09-241851","article-title":"The new oral anticoagulants.","volume":"115","author":"Garcia","year":"2010","journal-title":"Blood"},{"key":"2020071613173357100_B4","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Ed).","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"issue":"6","key":"2020071613173357100_B5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0049-3848(99)00189-9","article-title":"Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.","volume":"97","author":"Kearon","year":"2000","journal-title":"Thromb Res"},{"key":"2020071613173357100_B6","doi-asserted-by":"crossref","first-page":"199S","DOI":"10.1378\/chest.08-0672","article-title":"Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Ed).","volume":"133","author":"Patrono","year":"2008","journal-title":"Chest"},{"issue":"4","key":"2020071613173357100_B7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1755-5922.2009.00096.x","article-title":"Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist.","volume":"27","author":"Husted","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"2020071613173357100_B8","doi-asserted-by":"crossref","first-page":"40A","DOI":"10.1016\/j.amjcard.2008.11.023","article-title":"Advances in antiplatelet therapy: agents in clinical development.","volume":"103","author":"Angiolillo","year":"2009","journal-title":"Am J Cardiol"},{"issue":"4","key":"2020071613173357100_B9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2012.04641.x","article-title":"Reversal of the anti-platelet effects of aspirin and clopidogrel.","volume":"10","author":"Li","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2020071613173357100_B10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinternmed.2007.23","article-title":"Risk of thromboembolism with short-term interruption of warfarin therapy.","volume":"168","author":"Garcia","year":"2008","journal-title":"Arch Intern Med"},{"issue":"6","key":"2020071613173357100_B11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0025-6196(11)60891-4","article-title":"Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.","volume":"83","author":"Wysokinski","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"19","key":"2020071613173357100_B12","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1182\/blood-2011-02-329979","article-title":"Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach.","volume":"117","author":"Douketis","year":"2011","journal-title":"Blood"},{"issue":"16","key":"2020071613173357100_B13","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"2020071613173357100_B14","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"21","key":"2020071613173357100_B15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","article-title":"Management of anticoagulation before and after elective surgery.","volume":"336","author":"Kearon","year":"1997","journal-title":"N Engl J Med"},{"issue":"9757","key":"2020071613173357100_B16","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(10)60962-2","article-title":"Risk assessment for recurrent venous thrombosis.","volume":"376","author":"Kyrle","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"2020071613173357100_B17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"issue":"5","key":"2020071613173357100_B18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2010.03781.x","article-title":"Risk of stroke after surgery in patients with and without chronic atrial fibrillation.","volume":"8","author":"Kaatz","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2020071613173357100_B19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1538-7836.2011.04572.x","article-title":"Predictors of major bleeding in peri-procedural anticoagulation management.","volume":"10","author":"Tafur","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2020071613173357100_B20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH11-12-0827","article-title":"The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging rEgistRy (BORDER).","volume":"108","author":"Omran","year":"2012","journal-title":"Thromb Haemost"},{"issue":"6","key":"2020071613173357100_B21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jaad.2004.07.058","article-title":"A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery.","volume":"51","author":"Syed","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2020071613173357100_B22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.thromres.2009.01.007","article-title":"Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis.","volume":"124","author":"Jamula","year":"2009","journal-title":"Thromb Res"},{"issue":"1","key":"2020071613173357100_B23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-122-1-199501010-00006","article-title":"Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.","volume":"122","author":"White","year":"1995","journal-title":"Ann Intern Med"},{"issue":"3","key":"2020071613173357100_B24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2009.03685.x","article-title":"Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?","volume":"8","author":"Steib","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2020071613173357100_B25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0037-1615385","article-title":"Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?","volume":"80","author":"Barcellona","year":"1998","journal-title":"Thromb Haemost"},{"issue":"2","key":"2020071613173357100_B26","first-page":"260","article-title":"Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon.","volume":"90","author":"Fihn","year":"2003","journal-title":"Thromb Haemost"},{"issue":"12","key":"2020071613173357100_B27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch Intern Med"},{"issue":"12","key":"2020071613173357100_B28","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.0000142859.77578.C9","article-title":"Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.","volume":"110","author":"Kovacs","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"2020071613173357100_B29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11239-007-0022-z","article-title":"Low-dose vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.","volume":"24","author":"Woods","year":"2007","journal-title":"J Thromb Thrombolysis"},{"issue":"11","key":"2020071613173357100_B30","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1538-7836.2007.02729.x","article-title":"Bridging therapy in patients on long-term anticoagulants who require surgery: the Prospective Perioperative Enoxaparin Cohort Trial (PROSPECT).","volume":"5","author":"Dunn","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2020071613173357100_B31","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate\u2014a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity.","volume":"103","author":"van Ryn","year":"2010","journal-title":"Thromb Haemost"},{"issue":"13","key":"2020071613173357100_B32","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2011-10-378950","article-title":"How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch.","volume":"119","author":"Schulman","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2020071613173357100_B33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1538-7836.2010.04098.x","article-title":"Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.","volume":"9","author":"Hillarp","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2020071613173357100_B34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1160\/TH11-06-0391","article-title":"Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls.","volume":"107","author":"Samama","year":"2012","journal-title":"Thromb Haemost"},{"issue":"2","key":"2020071613173357100_B35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1213\/ANE.0b013e318203f38d","article-title":"Antiplatelet drugs: a review of their pharmacology and management in the perioperative period.","volume":"112","author":"Hall","year":"2011","journal-title":"Anesth Analg"},{"issue":"6","key":"2020071613173357100_B36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","article-title":"Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"2020071613173357100_B37","doi-asserted-by":"crossref","first-page":"35A","DOI":"10.1016\/j.amjcard.2008.11.022","article-title":"Monitoring platelet function to reduce the risk of ischemic and bleeding complicatons.","volume":"103","author":"Price","year":"2009","journal-title":"Am J Cardiol"},{"issue":"6","key":"2020071613173357100_B38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.athoracsur.2011.07.052","article-title":"Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection.","volume":"92","author":"Ceppa","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"2020071613173357100_B39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/bja\/aep373","article-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of \u2018bridging\u2019 antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel.","volume":"104","author":"Savonitto","year":"2010","journal-title":"Br J Anaesth"},{"issue":"3","key":"2020071613173357100_B40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery. A randomized controlled trial.","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"2020071613173357100_B41","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1538-7836.2012.04699.x","article-title":"Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study.","volume":"10","author":"Thiele","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2020071613173357100_B42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccl.2007.12.012","article-title":"Perioperative management of oral anticoagulation.","volume":"26","author":"O'Donnell","year":"2008","journal-title":"Cardiol Clin"},{"issue":"12","key":"2020071613173357100_B43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.5435\/00124635-201012000-00003","article-title":"Perioperative management of chronic anticoagulation in orthopaedic surgery.","volume":"18","author":"Thakur","year":"2010","journal-title":"J Am Acad Orthop Surg"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/24\/4699\/1360562\/zh805012004699.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/24\/4699\/1360562\/zh805012004699.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T02:55:47Z","timestamp":1687661747000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/24\/4699\/30971\/Perioperative-management-of-patients-on-chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,6]]},"references-count":43,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2012,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-05-423228","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,6]]}}}